Decay accelerating factor

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
Identifiers
Symbol CD55
Alt. Symbols DAF
Entrez 1604
HUGO 2665
OMIM 125240
RefSeq NM_000574
UniProt P08174
Other data
Locus Chr. 1 q32

WikiDoc Resources for

Decay accelerating factor

Articles

Most recent articles on Decay accelerating factor

Most cited articles on Decay accelerating factor

Review articles on Decay accelerating factor

Articles on Decay accelerating factor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Decay accelerating factor

Images of Decay accelerating factor

Photos of Decay accelerating factor

Podcasts & MP3s on Decay accelerating factor

Videos on Decay accelerating factor

Evidence Based Medicine

Cochrane Collaboration on Decay accelerating factor

Bandolier on Decay accelerating factor

TRIP on Decay accelerating factor

Clinical Trials

Ongoing Trials on Decay accelerating factor at Clinical Trials.gov

Trial results on Decay accelerating factor

Clinical Trials on Decay accelerating factor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Decay accelerating factor

NICE Guidance on Decay accelerating factor

NHS PRODIGY Guidance

FDA on Decay accelerating factor

CDC on Decay accelerating factor

Books

Books on Decay accelerating factor

News

Decay accelerating factor in the news

Be alerted to news on Decay accelerating factor

News trends on Decay accelerating factor

Commentary

Blogs on Decay accelerating factor

Definitions

Definitions of Decay accelerating factor

Patient Resources / Community

Patient resources on Decay accelerating factor

Discussion groups on Decay accelerating factor

Patient Handouts on Decay accelerating factor

Directions to Hospitals Treating Decay accelerating factor

Risk calculators and risk factors for Decay accelerating factor

Healthcare Provider Resources

Symptoms of Decay accelerating factor

Causes & Risk Factors for Decay accelerating factor

Diagnostic studies for Decay accelerating factor

Treatment of Decay accelerating factor

Continuing Medical Education (CME)

CME Programs on Decay accelerating factor

International

Decay accelerating factor en Espanol

Decay accelerating factor en Francais

Businness

Decay accelerating factor in the Marketplace

Patents on Decay accelerating factor

Experimental / Informatics

List of terms related to Decay accelerating factor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Decay accelerating factor (CD55) is a 70 kDa membrane protein that regulates the complement system on the cell surface. It prevents the assembly of the C3bBb complex (the C3-convertase of the alternative pathway) or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.

This glycoprotein is broadly distributed among hematopoietic and non-hematopoietic cells. It is a determinant for the Cromer blood group system.

Pathology

DAF is not expressed on paroxysmal nocturnal hemoglobinuria III (markedly abnormal) RBCs; however, this deficiency is not the cause of PNH.

See also

External links


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools